A positive trend in tumour-localized CAR T cell mass was observed for mice bearing cytokine-expressing tumours compared with those with unmodified tumours (+37% in SK-N-AS and +18% in SK-N-BE2c), although this did not reach statistical significance.
← all excerpts
Personalized CRISPR knock-in cytokine gene therapy to remodel the tumor microenvironment and enhance CAR T cell therapy in solid tumors.
1
—
—